ASCEND BY NTHRYS
Research Abroad Products

NGS Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Genomic Data Integration and Laboratory Information System
A unified cloud platform that consolidates NGS pipeline outputs, sample metadata, and clinical information into a searchable, audit-compliant data warehouse with built-in LIMS functionality. Streamlines laboratory workflows, enables batch reporting capabilities, and creates high-margin SaaS subscription revenue.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Tumor-Normal Somatic Mutation Detection and Oncology Workflow
A specialized bioinformatics pipeline optimized for cancer genomics with somatic variant filtering, copy number analysis, and tumor mutational burden calculation tailored for clinical oncology labs. Captures premium pricing from cancer centers and oncology research institutions seeking validated, ready-to-report solutions.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Microbial and Metagenomic Sequencing Classification Pipeline
A SaaS platform providing taxonomic classification, antimicrobial resistance profiling, and pathogen identification from NGS data for clinical microbiology and infectious disease diagnostics. Opens new market segments in clinical diagnostics with recurring licensing fees from hospital and reference laboratory networks.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Machine Learning-Driven Rare Disease Gene Candidate Prioritization
An AI-powered analysis module that integrates variant data, literature mining, and phenotypic information to rank candidate genes for rare disease diagnosis with proprietary machine learning models. Creates premium value-added service tier with subscription licensing to genetic testing companies and research hospitals.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Regulatory Compliance and Audit Trail Management Platform
A comprehensive SaaS solution ensuring NGS data provenance, pipeline validation documentation, and regulatory compliance for CAP, CLIA, and international certification standards with automated audit logging. Reduces compliance overhead by 60% and enables labs to rapidly achieve and maintain certifications, unlocking new service offerings.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Exome and Whole-Genome Sequence Analysis Turnkey Services
A managed services platform offering end-to-end exome and WGS analysis with customizable reporting pipelines, variant filtering strategies, and clinical interpretation as white-label or branded solutions. Enables genomic testing companies to scale operations without infrastructure investment while generating recurring per-sample revenue.
NGS Bioinformatics Pipeline SaaS Platform Dev Click to view more details →
Circulating Tumor DNA Detection SaaS Platform
A cloud-based platform that processes NGS data to identify and quantify ctDNA mutations with clinical-grade sensitivity and specificity. Enables early cancer detection and minimal residual disease monitoring, creating recurring revenue through subscription licensing to oncology clinics and hospital systems.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Multi-Gene Fusion Discovery and Reporting Tool
A specialized NGS analysis engine that detects gene fusions relevant to oncology with automated interpretation and clinical decision support. Generates revenue through lab certifications, licensing fees, and premium reporting tiers for targeted therapy recommendations.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Real-Time Tumor Mutation Burden Quantification Service
A commercial service that rapidly processes liquid biopsy samples to calculate TMB scores for immunotherapy patient stratification. Monetizes through per-sample analysis fees and strategic partnerships with pharmaceutical companies conducting biomarker-driven clinical trials.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
AI-Powered Variant Interpretation for Oncology Workflows
Machine learning software that classifies somatic variants in circulating DNA as pathogenic, benign, or variants of uncertain significance with explainable predictions. Delivers value through licensing to diagnostic labs, reducing manual curation time and enabling higher-volume processing capacity.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Longitudinal Tumor Tracking and Clonal Evolution Platform
A longitudinal data analytics platform that monitors individual tumor clones across serial liquid biopsy samples to predict treatment resistance and progression. Enables personalized oncology workflows and generates revenue through subscription tiers based on patient cohort size and analytical complexity.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →
Liquid Biopsy Reference Panel and Quality Control Suite
A commercial reagent and software package that provides certified control materials and automated QC analysis for NGS liquid biopsy assays. Creates recurring revenue through annual licensing, quality audits, and consumable sales to clinical and research laboratories worldwide.
NGS Oncology Liquid Biopsy Platform Development Click to view more details →